GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » C21 Investments Inc (XCNQ:CXXI) » Definitions » Revenue per Share

C21 Investments (XCNQ:CXXI) Revenue per Share : C$0.31 (TTM As of Sep. 2024)


View and export this data going back to 1987. Start your Free Trial

What is C21 Investments Revenue per Share?

C21 Investments's revenue per share for the three months ended in Sep. 2024 was C$0.09. C21 Investments's revenue per share for the trailing twelve months (TTM) ended in Sep. 2024 was C$0.31.

Warning Sign:

C21 Investments Inc revenue per share has been in decline over the past 3 years.

During the past 12 months, the average Revenue Per Share Growth Rate of C21 Investments was -3.10% per year. During the past 3 years, the average Revenue Per Share Growth Rate was -21.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate.

The historical rank and industry rank for C21 Investments's Revenue per Share or its related term are showing as below:

XCNQ:CXXI' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: -63.2   Med: 19.2   Max: 99.1
Current: -21.1

During the past 13 years, C21 Investments's highest 3-Year average Revenue Per Share Growth Rate was 99.10% per year. The lowest was -63.20% per year. And the median was 19.20% per year.

XCNQ:CXXI's 3-Year Revenue Growth Rate is ranked worse than
90.22% of 910 companies
in the Drug Manufacturers industry
Industry Median: 6.4 vs XCNQ:CXXI: -21.10

C21 Investments Revenue per Share Historical Data

The historical data trend for C21 Investments's Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

C21 Investments Revenue per Share Chart

C21 Investments Annual Data
Trend Jan14 Jan15 Jan16 Jan17 Jan18 Jan19 Jan20 Jan21 Jan22 Jan23
Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.11 0.64 0.41 0.34 0.32

C21 Investments Quarterly Data
Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Jun24 Sep24
Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.08 0.08 0.07 0.08 0.09

Competitive Comparison of C21 Investments's Revenue per Share

For the Drug Manufacturers - Specialty & Generic subindustry, C21 Investments's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


C21 Investments's PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, C21 Investments's PS Ratio distribution charts can be found below:

* The bar in red indicates where C21 Investments's PS Ratio falls into.



C21 Investments Revenue per Share Calculation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

C21 Investments's Revenue Per Share for the fiscal year that ended in Jan. 2023 is calculated as

Revenue Per Share (A: Jan. 2023 )=Revenue (A: Jan. 2023 )/Shares Outstanding (Diluted Average) (A: Jan. 2023 )
=38.773/122.881
=0.32

C21 Investments's Revenue Per Share for the quarter that ended in Sep. 2024 is calculated as

Revenue Per Share (Q: Sep. 2024 )=Revenue (Q: Sep. 2024 )/Shares Outstanding (Diluted Average) (Q: Sep. 2024 )
=10.172/120.048
=0.08

Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.31

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


C21 Investments  (XCNQ:CXXI) Revenue per Share Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:

Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.


Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.


C21 Investments Revenue per Share Related Terms

Thank you for viewing the detailed overview of C21 Investments's Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


C21 Investments Business Description

Traded in Other Exchanges
Address
601 West Cordova Street, Suite 170, Vancouver, BC, CAN, V6B 1G1
C21 Investments Inc is a vertically integrated cannabis company that cultivates, processes, and distributes quality cannabis and hemp-derived consumer products in the United States. The Company owns Silver State Relief and Silver State Cultivation in Nevada, including legacy Oregon brands Phantom Farms, Hood Oil and Eco Firma Farms. These brands produce and distribute a broad range of THC and CBD products from cannabis flowers, pre-rolls, cannabis oil, vaporizer cartridges and edibles.
Executives
Todd Andrew Harrison Director
Bruce Macdonald Director
Sky Pinnick Director
Leonard Werden Director
Michael Starrett Kidd Director, Senior Officer

C21 Investments Headlines

No Headlines